Synthesis and neuroprotective action of xyloketal derivatives in Parkinson's disease models.

Li S, Shen C, Guo W, Zhang X, Liu S, Liang F, Xu Z, Pei Z, Song H, Qiu L, Lin Y, Pang J.

Mar Drugs. 2013 Dec 18;11(12):5159-89. doi: 10.3390/md11125159.

Neuropsychiatric symptoms in Nigerian patients with Parkinson's disease.

Ojagbemi AA, Akinyemi RO, Baiyewu O.

Acta Neurol Scand. 2013 Jul;128(1):9-16. doi: 10.1111/ane.12062.

Clinical assessment of freezing of gait in Parkinson's disease from computer-generated animation.

Morris TR, Cho C, Dilda V, Shine JM, Naismith SL, Lewis SJ, Moore ST.

Gait Posture. 2013 Jun;38(2):326-9. doi: 10.1016/j.gaitpost.2012.12.011.

A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson's disease.

Hayashi A, Matsunaga N, Okazaki H, Kakimoto K, Kimura Y, Azuma H, Ikeda E, Shiba T, Yamato M, Yamada K, Koyanagi S, Ohdo S.

Neuromolecular Med. 2013 Jun;15(2):238-51. doi: 10.1007/s12017-012-8214-x.

Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease.

Quik M, Mallela A, Ly J, Zhang D.

Mov Disord. 2013 Sep;28(10):1398-406. doi: 10.1002/mds.25594.

[Role of demotivation and affective disorders in apathy in patients with Parkinson's disease without dementia and depression].

Delgadillo-Iniguez D, Derouesné C, Lacomblez L, Gély-Nargeot MC.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Jun;11(2):197-207. doi: 10.1684/pnv.2013.0404. French.

Olfaction in three genetic and two MPTP-induced Parkinson's disease mouse models.

Kurtenbach S, Wewering S, Hatt H, Neuhaus EM, Lübbert H.

PLoS One. 2013 Oct 30;8(10):e77509. doi: 10.1371/journal.pone.0077509.

Quality of life and depressive symptoms in Parkinson's disease after subthalamic deep brain stimulation: a 2-year follow-up study.

Tykocki T, Szalecki K, Koziara H, Nauman P, Mandat T.

Turk Neurosurg. 2013;23(3):379-84. doi: 10.5137/1019-5149.JTN.7184-12.1.

Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse.

Dranka BP, Gifford A, Ghosh A, Zielonka J, Joseph J, Kanthasamy AG, Kalyanaraman B.

Neurosci Lett. 2013 Aug 9;549:57-62. doi: 10.1016/j.neulet.2013.05.034.

Automated segmentation of transcranial sonographic images in the diagnostics of Parkinson's disease.

Sakalauskas A, Lukoševičius A, Laučkaitė K, Jegelevičius D, Rutkauskas S.

Ultrasonics. 2013 Jan;53(1):111-21. doi: 10.1016/j.ultras.2012.04.005.

[Impulsive-compulsive behaviours in a German Parkinson's disease outpatient sample].

Rohde K, Riedel O, Lueken U, Rietzel S, Fauser M, Ossig C, Reichmann H, Storch A.

Fortschr Neurol Psychiatr. 2013 Sep;81(9):503-10. doi: 10.1055/s-0033-1350457. German.

Costs of Parkinson's disease in a privately insured population.

Johnson SJ, Kaltenboeck A, Diener M, Birnbaum HG, Grubb E, Castelli-Haley J, Siderowf AD.

Pharmacoeconomics. 2013 Sep;31(9):799-806. doi: 10.1007/s40273-013-0075-0.

The role of basal ganglia in language production: evidence from Parkinson's disease.

Macoir J, Fossard M, Mérette C, Langlois M, Chantal S, Auclair-Ouellet N.

J Parkinsons Dis. 2013 Jan 1;3(3):393-7. doi: 10.3233/JPD-130182.

Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine?

Villalba RM, Smith Y.

Neuroscience. 2013 Oct 22;251:2-20. doi: 10.1016/j.neuroscience.2013.07.011. Review. Erratum in: Neuroscience. 2014 Feb 14;259:12.

Reduced step length, not step length variability is central to gait hypokinesia in people with Parkinson's disease.

Mak MK.

Clin Neurol Neurosurg. 2013 May;115(5):587-90. doi: 10.1016/j.clineuro.2012.07.014.